Key Insights

Highlights

Treatment Research

5 treatments under study, led by Surgical Resection

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT07062055Phase 2Recruiting

BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + Surgery/SBRT for BCLC-C HCC With PVTT and/or Oligometastases

Showing all 1 trials

Research Network

Common Treatments

  • Surgical Resection1
  • Hepatic Arterial Infusion Chemotherapy Haic1
  • Immunotherapy1
  • Local Therapy1
  • Antivegf1

Active Sponsors

  • Shandong Cancer Hospital and Institute1

Top Investigators

Related Conditions

  • Hepatocellular Carcinoma1
  • Radiotherapy1
  • Portal Vein Tumor Thrombus1
  • Immunotherapy1
  • Oligometastases1

Activity Timeline